This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chandra, S. Articles by Ohlstein, E. H. Search for Related Content PubMed PubMed Citation Articles by Chandra, S. Articles by Ohlstein, E. H.

(Circulation. 1998;97:2252-2258.)
© 1998 American Heart Association, Inc.

Basic Science Reports

Application of Serial In Vivo Magnetic Resonance Imaging to Evaluate the Efficacy of Endothelin Receptor Antagonist SB 217242 in the Rat Carotid Artery Model of Neointima Formation

Sudeep Chandra, PhD; Lynne V. Clark, BS; Robert W. Coatney, DVM, PhD; Le Phan, MSE; Susanta K. Sarkar, PhD; ; Eliot H. Ohlstein, PhD

From the Department of Physical and Structural Chemistry (S.C., L.P., S.K.S.), Laboratory Animal Science (R.W.C.), and Cardiovascular Pharmacology (L.V.C., E.H.O.), SmithKline Beecham Pharmaceuticals, King of Prussia, Pa.

Correspondence to Sudeep Chandra, PhD, MC: UW 2940, Department of Physical and Structural Chemistry, SmithKline Beecham Pharmaceuticals, 709, Swedeland Road, King of Prussia, PA 19406. E-mail sudeep-chandra-1{at}sbphrd.com

Background—Alleviating vascular restenosis after percutaneous transluminal angioplasty remains a formidable challenge. Although multiple factors have been implicated in the pathophysiology of this vascular remodeling disorder, only limited therapeutic success has been achieved. Endothelin (ET)-1 has recently been implicated in the pathogenesis of neointimal growth. We report the in vivo efficacy of SB 217242, a nonpeptide dual ET_A/ET_B receptor antagonist with high oral bioavailability, in the rat carotid artery balloon angioplasty model.

Methods and Results—The lumen volumes of carotid arteries were estimated serially with magnetic resonance imaging (MRI) at baseline and at day 7 and day 14 after balloon catheter–induced denudation of the carotid arterial wall in the rat. Histomorphometric analysis was performed at day 14 after surgery to quantitate intimal hyperplasia. Statistical analysis was performed with ANOVA followed by post hoc Newman-Keuls multiple comparison test. In comparison to vehicle-treated animals, a 20% protection (P<0.05) from reduction was shown in the estimated lumen volume with long-term administration of SB 217242 (15 mg/kg BID PO). Histologic analyses indicated a 42% decrease (P<0.05) in neointimal growth. The MRI lumen volumes had a significant correlation with the corresponding histologic indices.

Conclusions—Serial MRI provides the opportunity to assess the progression of vascular lumen volume in vivo after balloon angioplasty. MRI measurements can, in conjunction with in vitro histologic measurements, contribute to the understanding of the actions of pharmacologic agents in experimental models of neointima formation. With the use of serial MRI and histologic measurements, it is demonstrated that protection from both lumen volume reduction and neointima formation is obtained in this model by use of a potent, nonpeptide dual ET_A/ET_B receptor antagonist, SB 217242. Furthermore, this study provides additional support to the implication of ET-1 in the pathophysiology of neointima formation.

Key Words: magnetic resonance imaging • angioplasty • restenosis • endothelin

This article has been cited by other articles:

				M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF]

				P. D. Hockings, T. Roberts, G. J. Galloway, D. G. Reid, D. A. Harris, M. Vidgeon-Hart, P. H.E. Groot, K. E. Suckling, and G. M. Benson Repeated Three-Dimensional Magnetic Resonance Imaging of Atherosclerosis Development in Innominate Arteries of Low-Density Lipoprotein Receptor-Knockout Mice Circulation, September 24, 2002; 106(13): 1716 - 1721. [Abstract] [Full Text] [PDF]

				A. W Barolet, S. Babaei, R. Robinson, P. Picard, W. Tsui, N. Nili, F. Mohamed, O. Ornatsky, J. D Sparkes, D. J Stewart, et al. Administration of exogenous endothelin-1 following vascular balloon injury: early and late effects on intimal hyperplasia Cardiovasc Res, December 1, 2001; 52(3): 468 - 476. [Abstract] [Full Text] [PDF]

				E. H. Ohlstein, A. M. Romanic, L. V. Clark, R. D. Kapadia, S. K. Sarkar, R. Gagnon, and S. Chandra Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of the rat carotid artery Cardiovasc Res, September 1, 2000; 47(4): 759 - 768. [Abstract] [Full Text] [PDF]

				N. Kronemann, A. Bouloumie, S. Bassus, C. M. Kirchmaier, R. Busse, and V. B. Schini-Kerth Aggregating Human Platelets Stimulate Expression of Vascular Endothelial Growth Factor in Cultured Vascular Smooth Muscle Cells Through a Synergistic Effect of Transforming Growth Factor-{beta}1 and Platelet-Derived Growth FactorAB Circulation, August 24, 1999; 100(8): 855 - 860. [Abstract] [Full Text] [PDF]